Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$332M |
| 2 |
ExxonMobil
XOM
|
+$283M |
| 3 |
Verizon
VZ
|
+$165M |
| 4 |
Yum China
YUMC
|
+$137M |
| 5 |
Chevron
CVX
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$862M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$427M |
| 4 |
Dimensional International Small Cap Value ETF
DISV
|
+$421M |
| 5 |
Apple
AAPL
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Technology | 15.25% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMLR
2976
DELISTED
Semler Scientific
SMLR
| $691K | ﹤0.01% |
18,408
-11,133
| -38% | -$420K |
|
|
GRTS
2977
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $690K | ﹤0.01% |
268,413
+108,613
| +68% | +$346K |
|
2978
Beam Therapeutics
BEAM
$2.7B
| $685K | ﹤0.01% |
14,375
-3,754
| -21% | -$214K |
|
|
SVT
2979
DELISTED
Servotronics
SVT
| $684K | ﹤0.01% |
60,719
+231
| +0.4% | +$2.58K |
|
2980
Gaia
GAIA
$47.6M
| $680K | ﹤0.01% |
279,792
-38,771
| -12% | -$136K |
|
2981
Milestone Pharmaceuticals
MIST
$133M
| $673K | ﹤0.01% |
73,274
-2,072
| -3% | -$15.7K |
|
2982
NetSol Technologies
NTWK
$51.3M
| $672K | ﹤0.01% |
214,246
-12,223
| -5% | -$41.1K |
|
2983
Union Bankshares
UNB
$108M
| $663K | ﹤0.01% |
29,306
| – | – |
|
|
NEXN
2984
Nexxen International
NEXN
$583M
| $657K | ﹤0.01% |
95,090
-1,457
| -2% | -$12.8K |
|
|
LMST
2985
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
| $652K | ﹤0.01% |
33,209
+634
| +2% | +$12.4K |
|
2986
Canadian Solar
CSIQ
$927M
| $650K | ﹤0.01% |
17,446
-316
| -2% | -$12K |
|
|
CURO
2987
DELISTED
CURO Group Holdings Corp.
CURO
| $643K | ﹤0.01% |
160,100
-101,855
| -39% | -$656K |
|
2988
Mexco Energy
MXC
$17.9M
| $639K | ﹤0.01% |
39,364
-814
| -2% | -$14.3K |
|
2989
ALX Oncology
ALXO
$268M
| $636K | ﹤0.01% |
+66,473
| New | +$775K |
|
2990
RingCentral
RNG
$4.77B
| $632K | ﹤0.01% |
15,817
-15,087
| -49% | -$723K |
|
2991
Live Ventures
LIVE
$29.4M
| $628K | ﹤0.01% |
25,082
+8,533
| +52% | +$244K |
|
|
PHLT
2992
DELISTED
Performant Healthcare Inc
PHLT
| $627K | ﹤0.01% |
339,337
+1,243
| +0.4% | +$2.89K |
|
|
ONEM
2993
DELISTED
1Life Healthcare
ONEM
| $627K | ﹤0.01% |
+36,545
| New | +$574K |
|
|
VIRX
2994
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $625K | ﹤0.01% |
+146,331
| New | +$620K |
|
2995
Verastem
VSTM
$547M
| $612K | ﹤0.01% |
59,983
-53,938
| -47% | -$752K |
|
2996
Rapid7
RPD
$642M
| $611K | ﹤0.01% |
14,248
-7,143
| -33% | -$441K |
|
|
PCH
2997
DELISTED
PotlatchDeltic
PCH
| $608K | ﹤0.01% |
14,826
-516
| -3% | -$23.7K |
|
2998
Ocular Therapeutix
OCUL
$1.85B
| $607K | ﹤0.01% |
146,122
+38,310
| +36% | +$193K |
|
2999
Outset Medical
OM
$87.5M
| $606K | ﹤0.01% |
2,533
-359
| -12% | -$96.1K |
|
|
BNFT
3000
DELISTED
Benefitfocus, Inc.
BNFT
| $606K | ﹤0.01% |
95,452
-83,868
| -47% | -$622K |
|
Similar funds
Dimensional Fund Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Dimensional Fund Advisors held 3,606 positions worth $260B, down 6.6% from $279B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q3 2022 filing shows 143 new, 1,920 increased, 1,329 reduced and 119 closed positions. Its largest new stake was Yum China: 2,857,283 shares worth $135M. The largest sale was Dimensional Emerging Markets Core Equity 2 ETF, an estimated $941M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q3 2022 buy was Yum China: 2,857,283 shares worth $135M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q3 2022, an estimated $332M increase.
- Dimensional Fund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $219M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Core Equity 2 ETF in Q3 2022, selling an estimated $941M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $260B portfolio in Q3 2022.
- Dimensional Fund Advisors opened 143 new positions and closed 119 in Q3 2022.
- Dimensional Fund Advisors's portfolio value fell 6.6% quarter-over-quarter to $260B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.